CoChat

Optimised metrics for CRISPR-KO screens with second-generation gRNA libraries

Ong, Swee Hoe, Li, Yilong, Koike-Yusa, Hiroko, Yusa, Kosuke · 2017 · Scientific Reports
Cited by 45

The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.

Abstract

Genome-wide CRISPR-based knockout (CRISPR-KO) screening is an emerging technique which enables systematic genetic analysis of a cellular or molecular phenotype in question. Continuous improvements, such as modifications to the guide RNA (gRNA) scaffold and the development of gRNA on-target prediction algorithms, have since been made to increase their screening performance. We compared the performance of three available second-generation human genome-wide CRISPR-KO libraries that included at least one of the improvements, and examined the effect of gRNA scaffold, number of gRNAs per gene and number of replicates on screen performance. We identified duplicated screens using a library with 6 gRNAs per gene as providing the best trade-off. Despite the improvements, we found that each improved library still has library-specific false negatives and, for the first time, estimated the false negative rates of CRISPR-KO screens, which are between 10% and 20%. Our newly-defined optimal screening parameters would be helpful in designing screens and constructing bespoke gRNA libraries.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41598-017-07827-z

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 23 references

Research works printed but not linked: 30

  1. Barrangou, R. et al. CRISPR provides acquired resistance against viruses in prokaryotes. Science 315, 1709–1712, doi:10.1126/science.1138140 (2007). · DOI · Paper page
  2. Jinek, M. et al. A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity. Science 337, 816–821, doi:10.1126/science.1225829 (2012). · DOI · Paper page
  3. Doudna, J. A. & Charpentier, E. Genome editing. The new frontier of genome engineering with CRISPR-Cas9. Science 346, 1258096, doi:10.1126/science.1258096 (2014). · DOI · Paper page
  4. Cong, L. et al. Multiplex genome engineering using CRISPR/Cas systems. Science 339, 819–823, doi:10.1126/science.1231143 (2013). · DOI · Paper page
  5. Mali, P. et al. RNA-guided human genome engineering via Cas9. Science 339, 823–826, doi:10.1126/science.1232033 (2013). · DOI · Paper page
  6. Hilton, I. B. et al. Epigenome editing by a CRISPR-Cas9-based acetyltransferase activates genes from promoters and enhancers. Nat Biotechnol 33, 510–517, doi:10.1038/nbt.3199 (2015). · DOI · Paper page
  7. Morita, S. et al. Targeted DNA demethylation in vivo using dCas9-peptide repeat and scFv-TET1 catalytic domain fusions. Nat Biotechnol 34, 1060–1065, doi:10.1038/nbt.3658 (2016). · DOI · Paper page
  8. Komor, A. C., Kim, Y. B., Packer, M. S., Zuris, J. A. & Liu, D. R. Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage. Nature 533, 420–424, doi:10.1038/nature17946 (2016). · DOI · Paper page
  9. Gilbert, L. A. et al. CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotes. Cell 154, 442–451, doi:10.1016/j.cell.2013.06.044 (2013). · DOI · Paper page
  10. Shalem, O. et al. Genome-Scale CRISPR-Cas9 Knockout Screening in Human Cells. Science 343, 84–87, doi:10.1126/science.1247005 (2014). · DOI · Paper page
  11. Hsu, P. D. et al. DNA targeting specificity of RNA-guided Cas9 nucleases. Nat Biotechnol 31, 827–832, doi:10.1038/nbt.2647 (2013). · DOI · Paper page
  12. Heigwer, F., Kerr, G. & Boutros, M. E-CRISP: fast CRISPR target site identification. Nat Methods 11, 122–123, doi:10.1038/nmeth.2812 (2014). · DOI · Paper page
  13. Hodgkins, A. et al. WGE: a CRISPR database for genome engineering. Bioinformatics 31, 3078–3080, doi:10.1093/bioinformatics/btv308 (2015). · DOI · Paper page
  14. Chari, R., Mali, P., Moosburner, M. & Church, G. M. Unraveling CRISPR-Cas9 genome engineering parameters via a library-on-library approach. Nat Methods 12, 823–826, doi:10.1038/nmeth.3473 (2015). · DOI · Paper page
  15. Bae, S., Kweon, J., Kim, H. S. & Kim, J. S. Microhomology-based choice of Cas9 nuclease target sites. Nat Methods 11, 705–706, doi:10.1038/nmeth.3015 (2014). · DOI · Paper page
  16. Sanjana, N. E., Shalem, O. & Zhang, F. Improved vectors and genome-wide libraries for CRISPR screening. Nat Methods 11, 783–784, doi:10.1038/nmeth.3047 (2014). · DOI · Paper page
  17. Hart, T. et al. High-Resolution CRISPR Screens Reveal Fitness Genes and Genotype-Specific Cancer Liabilities. Cell 163, 1515–1526, doi:10.1016/j.cell.2015.11.015 (2015). · DOI · Paper page
  18. Ma, H. et al. A CRISPR-Based Screen Identifies Genes Essential for West-Nile-Virus-Induced Cell Death. Cell Rep 12, 673–683, doi:10.1016/j.celrep.2015.06.049 (2015). · DOI · Paper page
  19. Chen, B. et al. Dynamic imaging of genomic loci in living human cells by an optimized CRISPR/Cas system. Cell 155, 1479–1491, doi:10.1016/j.cell.2013.12.001 (2013). · DOI · Paper page
  20. Mohr, S. E., Smith, J. A., Shamu, C. E., Neumuller, R. A. & Perrimon, N. RNAi screening comes of age: improved techniques and complementary approaches. Nat Rev Mol Cell Biol 15, 591–600, doi:10.1038/nrm3860 (2014). · DOI · Paper page
  21. Park, R. J. et al. A genome-wide CRISPR screen identifies a restricted set of HIV host dependency factors. Nat Genet 49, 193–203, doi:10.1038/ng.3741 (2017). · DOI · Paper page
  22. Fu, Y. et al. High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells. Nat Biotechnol 31, 822–826, doi:10.1038/nbt.2623 (2013). · DOI · Paper page
  23. Munoz, D. M. et al. CRISPR Screens Provide a Comprehensive Assessment of Cancer Vulnerabilities but Generate False-Positive Hits for Highly Amplified Genomic Regions. Cancer Discov 6, 900–913, doi:10.1158/2159-8290.CD-16-0178 (2016). · DOI · Paper page
  24. Aguirre, A. J. et al. Genomic Copy Number Dictates a Gene-Independent Cell Response to CRISPR/Cas9 Targeting. Cancer Discov 6, 914–929, doi:10.1158/2159-8290.CD-16-0154 (2016). · DOI · Paper page
  25. Cross, B. C. et al. Increasing the performance of pooled CRISPR-Cas9 drop-out screening. Sci Rep 6, 31782, doi:10.1038/srep31782 (2016). · DOI · Paper page
  26. Dang, Y. et al. Optimizing sgRNA structure to improve CRISPR-Cas9 knockout efficiency. Genome Biol 16, 280, doi:10.1186/s13059-015-0846-3 (2015). · DOI · Paper page
  27. Diaz, A. A., Qin, H., Ramalho-Santos, M. & Song, J. S. HiTSelect: a comprehensive tool for high-complexity-pooled screen analysis. Nucleic Acids Res 43, e16, doi:10.1093/nar/gku1197 (2015). · DOI
  28. Yu, J., Silva, J. & Califano, A. ScreenBEAM: a novel meta-analysis algorithm for functional genomics screens via Bayesian hierarchical modeling. Bioinformatics 32, 260–267, doi:10.1093/bioinformatics/btv556 (2016). · DOI
  29. Winter, J. et al. caRpools: an R package for exploratory data analysis and documentation of pooled CRISPR/Cas9 screens. Bioinformatics 32, 632–634, doi:10.1093/bioinformatics/btv617 (2016). · DOI · Paper page
  30. Steinhart, Z. et al. Genome-wide CRISPR screens reveal a Wnt-FZD5 signaling circuit as a druggable vulnerability of RNF43-mutant pancreatic tumors. Nat Med 23, 60–68, doi:10.1038/nm.4219 (2017). · DOI · Paper page

Cited by

See all 45

Metadata

Authors
Ong, S. H., Li, Y., Koike-Yusa, H., & Yusa, K.
Venue
Scientific Reports
Published
2017-08-07
Volume
7
Issue
1
ISSN
2045-2322
Cited by
45
References
23
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Optimised metrics for CRISPR-KO screens with second-generation gRNA libraries. https://app.cochat.ai/papers/10.1038/s41598-017-07827-z
The paper
Ong, S. H., Li, Y., Koike-Yusa, H., & Yusa, K. (2017). Optimised metrics for CRISPR-KO screens with second-generation gRNA libraries. Scientific Reports. https://doi.org/10.1038/s41598-017-07827-z

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.